PEB ASX · Health Care

Pacific Edge Ltd

Announcements, last 12 months: 65
Price sensitive, last 12 months: 17
Followed on InvestorPA: Low (Outside the 20% most-followed companies on InvestorPA)

Latest announcements

Released	Headline	Actions
21 Oct 2026, 2:36 PM	Change in substantial holding
19 Oct 2026, 7:30 AM	Pacific Edge Advances US Commercial Recovery Price sensitive
7 Oct 2026, 2:24 PM	Change in substantial holding
1 Oct 2026, 12:44 PM	NZX - Capital Change Notice - Expiry of Options
1 Oct 2026, 12:43 PM	NZX - Capital Change Notice - Exercise of Options
1 Oct 2026, 12:29 PM	Notification of cessation of securities - PEB
1 Oct 2026, 12:26 PM	Application for quotation of securities - PEB
14 Sep 2026, 2:36 PM	NZX D&O Disclosures - Peter Meintjes & Grant Gibson
14 Sep 2026, 2:05 PM	NZX - Capital Change Notice - Pacific Edge - 14 September 26
14 Sep 2026, 1:54 PM	Notification regarding unquoted securities - PEB

Guidance history

28 Feb 2025

Pacific Edge anticipates an uplift in demand for Cxbladder tests as more clinicians in the US and around the world begin to observe the updated AUA guideline and incorporate the tests into care pathways for the evaluation and management of patients presenting with microhematuria.

Most followed in Health Care

PME Pro Medicus Ltd
AHC Austco Healthcare Ltd
CSL CSL Ltd
RMD Resmed Inc
TLX TELIX Pharmaceuticals Ltd
CGS Cogstate Ltd
ALC Alcidion Group Ltd
CSX Cleanspace Holdings Ltd

Follow PEB to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.